Doctors Details

Dr. Ankur Nandan Varshney
Consultant15 Years of Experience
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
MBBS, MD, DM
Reg. No.:69367, Delhi Medical Council
English
Get Free Evaluation
About Dr. Ankur Nandan Varshney
- Dr. Ankur Nandan Varshney is an accomplished medical oncologist with an impressive 14 years of experience.
- He specializes in areas such as cancer immunotherapy, breast cancer, GI malignancies, lung cancer, urogenital cancers, multiple myeloma, lymphoma, leukemia, pediatric solid tumors, stem cell transplantation, and pain and palliative care.
- His educational qualifications include an MBBS from Banaras Hindu University 2010, an MD in General Medicine from Banaras Hindu University 2014, and a DM in Medical Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi, 2021
- Dr. Varshney has presented numerous papers at international conferences, showcasing his expertise and dedication to advancing the field of medical oncology.
- He is committed to delivering exceptional patient care while actively contributing to the progress of medical oncology.
Awards of Dr. Ankur Nandan Varshney
- Won Deeptanshu Vedanta Gupta Gold Medal
- Won “Best Poster Prize and Gold Medal†at UP-APICON 2013
- Selected and attended ESMO Lung preceptorship in November 2020
- Won ESH scholarship award for the 22nd John Goldman Conference 2020
- Won a Young Investigator travel grant for the SOHO Conference 2021.
- Selected for Young Investigator Award for SOHO conference 2022
Paper Published by Dr. Ankur Nandan Varshney
- CML-362 Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients of Chronic Myeloid Leukemia–Chronic Phase and Correlate Its In-Vivo Activity With STAT1, STAT5, and AKT 1 Levels
- 515P Prognostic significance of elevated serum tumor markers (STM) after the first cycle of chemotherapy in patients with intermediate and poor risk non-seminomatous testicular germ cell tumors (NSGCT)
- Prognostic significance of raised serum tumor markers (STM) after two cycles of chemotherapy in men with intermediate- and poor-risk non-seminomatous testicular germ cell tumors (NSGCT) treated at a single-center in India.
- Comparison of quality of life (QoL) in survivors of testicular nonseminomatous germ cell tumor (NSGCT) with age-matched controls using EORTC QLQ-C30 questionnaire.
- CML-268: Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients with CML-CP
- Poster: CML-268: Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients with CML-CP
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- 471PChemotherapy in advanced thymic malignancies
- Primary Plasma Cell Leukemia: a retrospective series from a tertiary care center in India
- Preemptive plerixafor-based mobilization strategy in multiple myeloma patients for autologous stem cell transplantation
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- Preemptive plerixafor-based mobilization strategy in multiple myeloma patients for autologous stem cell transplantation
Experience of Dr. Ankur Nandan Varshney
- All India Institute of Medical Sciences (AIIMS), New DelhiÂ
- Safdarjung Hospital New DelhiÂ
- National Cancer Institute Jhajjar Haryana
Education of Dr. Ankur Nandan Varshney
- MBBS, Banaras Hindu University, 2010
- MD (General Medicine), Banaras Hindu University, 2014
- DM (Medical Oncology), All India Institute of Medical Sciences (AIIMS), New Delhi, 2021
Top Oncology Doctors in India
Delivering Quality Care, Trusted Globally